Ingrezza 40 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DR25F8QMW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,352
Award facts
- Contract value 100% obligated
- $7,352.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a Delivery Order contract valued at $7,352.24 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units). This is a firm fixed price delivery order without set-aside designation, with an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. Ingrezza is a prescription medication used to treat tardive dyskinesia, a neurological movement disorder, and represents part of the company's extensive pharmaceutical supply portfolio supporting federal medical procurement needs.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceuticals, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's receipt of this competitively awarded delivery order demonstrates its continued capability to fulfill the Department of Defense's specialized pharmaceutical requirements through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR25F8QMW?
SPE2DR25F8QMW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DR25F8QMW worth?
The government has obligated $7,352 on SPE2DR25F8QMW.
Is contract SPE2DR25F8QMW an order under another contract?
Yes. SPE2DR25F8QMW is a delivery order under SPE2DB24D1201, an indefinite delivery contract.
Was contract SPE2DR25F8QMW competed?
The extent of competition for SPE2DR25F8QMW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award